Načítá se...
Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis
BACKGROUND AND OBJECTIVES: Rates of malignant melanoma are continuing to increase, and until recently effective treatments were lacking. However, since 2011 three immunotherapeutic agents, known as checkpoint inhibitors, have been approved. This review aims to establish whether these three drugs – i...
Uloženo v:
| Vydáno v: | Clin Cosmet Investig Dermatol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5580705/ https://ncbi.nlm.nih.gov/pubmed/28883738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S120877 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|